IDH2 Gene IDH2 Selective Sequencing of Exon 4 NGS Genetic DNA Test
Introduction
The IDH2 Gene IDH2 Selective Sequencing of Exon 4 NGS Genetic DNA Test is a vital diagnostic procedure utilized in the field of oncology. This test is designed to detect mutations in the IDH2 gene, which can play a significant role in the development and progression of various cancers. By identifying these mutations, healthcare providers can tailor treatment strategies to improve patient outcomes.
What the Test Measures
This genetic test specifically measures alterations in the IDH2 gene through Next-Generation Sequencing (NGS) technology. It focuses on exon 4 of the IDH2 gene, which is crucial for understanding the genetic basis of certain cancers.
Who Should Consider This Test
Patients diagnosed with cancers such as acute myeloid leukemia (AML) or gliomas may benefit from the IDH2 Gene test. It is particularly recommended for individuals with:
- A family history of cancer
- Symptoms indicative of malignancies
- Previous diagnoses of IDH2-related cancers
Benefits of Taking the Test
Taking the IDH2 Gene IDH2 Selective Sequencing of Exon 4 NGS Genetic DNA Test offers numerous advantages, including:
- Personalized treatment options based on genetic findings
- Improved understanding of cancer prognosis
- Informed decisions regarding participation in clinical trials
- Enhanced monitoring of treatment response
Understanding Your Results
Results from the IDH2 Gene test will provide insights into the presence or absence of mutations. Your healthcare provider will discuss the implications of your results, guiding you through potential treatment pathways and further testing if necessary.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| IDH2 Gene IDH2 Selective Sequencing of Exon 4 NGS Genetic DNA Test | 400000 NGN | 560000 NGN |
Booking the Test
To ensure accurate results, a clinical history of the patient is required along with a genetic counseling session to create a pedigree chart of family members affected by IDH2 mutations. Samples can be collected as blood or extracted DNA, or even one drop of blood on an FTA card.
For more information or to book the IDH2 Gene IDH2 Selective Sequencing of Exon 4 NGS Genetic DNA Test, please call or WhatsApp us at +2348077798758.
Turnaround Time
The test results will typically be available within 3 to 4 weeks, allowing for timely management of your health.
